The role of the community pharmacist in fulfilling information needs of patients starting oral antidiabetics.
BACKGROUND
Community pharmacy is in the middle of a paradigm shift from provider of medication to provider of care around medication. Much of this care involves giving information to patients so as to maximize pharmacotherapy outcomes; however, this is not necessarily recognized by patients. The initiation of chronic medication for diseases, such as type 2 diabetes mellitus (T2DM), arouses much uncertainty in patients, and it is not certain how information provision roles by pharmacists are viewed.


OBJECTIVE
To obtain insight in the information needs of patients who have recently started treatment with oral antidiabetics and to investigate the opportunities for pharmacy regarding the provision of information for patients with T2DM.


METHODS
A qualitative study with both semistructured telephone interviews and patient focus group discussions was conducted. Individual patients' comments were categorized and used in a strengths, weaknesses, opportunities, and threats (SWOT) analysis exploring the role of the community pharmacist in the field of providing information at the moment of initiation of T2DM oral medication.


RESULTS
From interviews with 42 patients and 2 focus groups, discussions emerged that the general practitioner (GP) does not fulfill all information needs. For the pharmacist, there is an opportunity, as patients feel a need for information and like to discuss drug-related issues. SWOT analysis revealed main strengths of the pharmacy as "expertise" and "service and kindness." Together with more cooperation with GPs and nurse practitioners, these strengths give the pharmacist the opportunity to further develop pharmaceutical care activities.


CONCLUSIONS
Pharmacists are challenged to increase their visibility as health care provider while keeping logistic service on a high level and improving cooperation with other health care providers.
Division of Pharmacoepidemiology & Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. e.j.f.lamberts@uu.nl
Egbert J F
EJ
Lamberts
Marcel L
ML
Bouvy
Rolf P
RP
van Hulten
D000284:Administration, Oral; D000368:Aged; D003157:Community Pharmacy Services / Q000458:organization & administration*; D003625:Data Collection; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005260:Female; D017144:Focus Groups; D058005:General Practitioners / Q000458:organization & administration; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic / Q000379:methods*; D010595:Pharmacists / Q000458:organization & administration*; D010818:Practice Patterns, Physicians' / Q000458:organization & administration; D024382:Professional Role
D007004:Hypoglycemic Agents